RICHMOND, Va., Dec. 12, 2018 /PRNewswire/ -- Kaléo, a privately-held pharmaceutical company, today announced that it will offer an authorized generic of its EVZIO® (naloxone HCl injection) take home ...
The Food and Drug Administration has approved an auto-injector developed by a Richmond pharmaceutical company for emergency treatment of an overdose involving powerful painkillers. EVZIO is a ...
In addition to the new authorized generic, Evzio is now available at $178 per carton (2 auto-injectors per carton) for government agencies, first responders, health departments, and other qualifying ...
(Reuters) - Kaleo Inc, which came under fire last year for the high price of its device to treat opioid overdoses, on Thursday said it is expanding nonprescription access to the Evzio injector and ...
After watching patients in need struggle to get access to naloxone, we made a commitment, starting in 2016, to make EVZIO® available for $0 out of pocket for all patients with commercial insurance and ...
While naloxone effectively reverses the effects of an opioid overdose, medical experts said the rising price of one form of the drug may limit overall access to the life-saving medicine. Opioid ...
Richmond-based Kaleo has announced a program that allows local law enforcement agencies to receive medicine to treat emergency opioid overdoses for free. The pharmaceutical company says the Henrico ...
First responders around the state will get a naloxone auto-injector aimed at stopping opioid overdoses under a grant announced Wednesday. But after the three-year grant from drugmaker Kaleo runs out, ...
Kaléo rolled out two initiatives to increase access to its opioid overdose reversal drug Evzio, the company announced April 5. Here are four things to know. 1. Kaléo already covers out-of-pocket costs ...
BOSTON - The price of an injectable overdose-reversing drug designed for use by laypeople has skyrocketed, prompting outrage from first-responders, health advocates and elected officials. Kaléo, a ...
A drugmaker capitalized on the opioid epidemic by hiking the price of its overdose-reversing drug by 600 percent during the height of the crisis, Senate investigators charged Sunday. The Permanent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results